A detailed history of True Private Wealth Advisors transactions in Amgen Inc stock. As of the latest transaction made, True Private Wealth Advisors holds 841 shares of AMGN stock, worth $243,065. This represents 0.03% of its overall portfolio holdings.

Number of Shares
841
Previous 2,779 69.74%
Holding current value
$243,065
Previous $868,000 68.89%
% of portfolio
0.03%
Previous 0.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $599,578 - $653,842
-1,938 Reduced 69.74%
841 $270,000
Q2 2024

Jul 16, 2024

BUY
$262.75 - $319.31 $13,663 - $16,604
52 Added 1.91%
2,779 $868,000
Q1 2024

Apr 25, 2024

BUY
$268.87 - $324.56 $43,019 - $51,929
160 Added 6.23%
2,727 $775,000
Q4 2023

Jan 30, 2024

BUY
$255.7 - $288.46 $182,569 - $205,960
714 Added 38.53%
2,567 $739,000
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $59,691 - $74,108
273 Added 17.28%
1,853 $498,000
Q2 2023

Aug 11, 2023

BUY
$214.27 - $253.37 $40,497 - $47,886
189 Added 13.59%
1,580 $350,000
Q1 2023

May 11, 2023

SELL
$225.79 - $275.2 $3,838 - $4,678
-17 Reduced 1.21%
1,391 $336,000
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $18,322 - $23,280
80 Added 6.02%
1,408 $369,000
Q3 2022

Nov 04, 2022

BUY
$224.46 - $253.15 $31,199 - $35,187
139 Added 11.69%
1,328 $299,000
Q2 2022

Jul 28, 2022

BUY
$230.71 - $256.74 $1,153 - $1,283
5 Added 0.42%
1,189 $289,000
Q1 2022

May 09, 2022

SELL
$219.27 - $242.57 $102,837 - $113,765
-469 Reduced 28.37%
1,184 $279,000
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $30,030 - $34,367
-151 Reduced 8.37%
1,653 $371,000
Q3 2021

Nov 05, 2021

SELL
$212.27 - $248.7 $1,485 - $1,740
-7 Reduced 0.39%
1,804 $383,000
Q2 2021

Aug 10, 2021

SELL
$233.58 - $259.14 $89,694 - $99,509
-384 Reduced 17.49%
1,811 $441,000
Q1 2021

May 12, 2021

BUY
$221.91 - $258.6 $98,971 - $115,335
446 Added 25.5%
2,195 $546,000
Q4 2020

Jan 11, 2021

BUY
$216.38 - $257.67 $6,491 - $7,730
30 Added 1.75%
1,749 $402,000
Q3 2020

Oct 09, 2020

BUY
$234.65 - $260.95 $114,509 - $127,343
488 Added 39.64%
1,719 $436,000
Q2 2020

Jul 07, 2020

BUY
$197.81 - $242.74 $27,297 - $33,498
138 Added 12.63%
1,231 $290,000
Q1 2020

Apr 20, 2020

SELL
$182.24 - $241.7 $427,899 - $567,511
-2,348 Reduced 68.24%
1,093 $221,000
Q4 2019

Jan 27, 2020

SELL
$189.21 - $243.2 $2,838 - $3,648
-15 Reduced 0.43%
3,441 $829,000
Q3 2019

Oct 09, 2019

SELL
$174.11 - $208.62 $55,018 - $65,923
-316 Reduced 8.38%
3,456 $668,000
Q2 2019

Aug 01, 2019

BUY
$166.7 - $195.41 $23,338 - $27,357
140 Added 3.85%
3,772 $695,000
Q1 2019

Apr 25, 2019

SELL
$180.87 - $203.88 $21,523 - $24,261
-119 Reduced 3.17%
3,632 $690,000
Q4 2018

Jan 14, 2019

BUY
$178.4 - $208.25 $63,867 - $74,553
358 Added 10.55%
3,751 $730,000
Q3 2018

Oct 18, 2018

SELL
$185.29 - $208.89 $13,896 - $15,666
-75 Reduced 2.16%
3,393 $0
Q2 2018

Jul 13, 2018

BUY
$166.05 - $186.51 $111,419 - $125,148
671 Added 23.99%
3,468 $640,000
Q1 2018

Apr 25, 2018

BUY
$169.43 - $198.0 $7,624 - $8,910
45 Added 1.64%
2,797 $476,000
Q4 2017

Jan 19, 2018

BUY
$168.79 - $188.59 $65,828 - $73,550
390 Added 16.51%
2,752 $478,000
Q2 2017

Aug 07, 2017

BUY
N/A
2,362
2,362 $406,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track True Private Wealth Advisors Portfolio

Follow True Private Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on True Private Wealth Advisors with notifications on news.